Disease control in advanced Hodgkin lymphoma

Improved OS with obinutuzumab in the CLL11 study

Rituximab in combination therapies for FL: Interim results

Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results

Mapping 3D genome dynamics in B cells

Update on bb2121 for relapsed myeloma

Pancreatic survival improved with trial chemotherapy regimen after surgery

Pre-operative chemotherapy with radiation may help people with pancreatic cancer live longer

Pembrolizumab works better than chemotherapy alone as initial treatment for NSCLC

Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer treatment

Genetic testing of early breast tumours could allow patients to go without chemo

Atezolizumab with chemotherapy improves PFS in squamous NSCLC